What is the share price of Hiran Orgochem Ltd (506170)?

Company share prices are keep on changing according to the market conditions. The current trading price of Hiran Orgochem Ltd (506170) on 01-Jan-1970 05:30:00 at 05:30 is .

What is the P/E ratio of Hiran Orgochem?

The latest standalone P/E ratio of Hiran Orgochem as of 01-Jan-1970 is 5.56.

What is the P/B ratio of Hiran Orgochem Ltd (506170)?

The latest standalone P/B ratio of Hiran Orgochem Ltd (506170) as of 01-Jan-1970 is -0.14.

What is the 52-week high and low of Hiran Orgochem Ltd (506170)?

The 52-week high of Hiran Orgochem Ltd (506170) is Rs. 0.48 and the 52-week low is Rs. 0.44.

Hiran Orgochem Ltd (506170) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Hiran Orgochem Ltd (506170)
Brand: Hiran Orgochem

Hiran Orgochem Ltd (506170)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 506170 NSE: Pharmaceuticals & Drugs | Small Cap | Hiran Orgochem Share Price

Hiran Orgochem Ltd (506170)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 506170 NSE: Pharmaceuticals & Drugs | Small Cap | Hiran Orgochem Share Price

Key Metrics

Valuation Multiples

Market Cap

₹5 Cr.

Current Price

₹0

52-Week Low / High

₹0 / 0

TTM EPS

₹0.1

TTM Sales

₹0 Cr.

Book Value per Share

₹-3.5

P/E Ratio

5.56

Industry PE

49.8

Price to Book (P/B)

-0.14

Price to Sales (P/S)

0.00

EV/EBITDA

71.51

Dividend Yield

NAN%

Profitability Efficiency

Return on Equity (ROE)

0.00%

Return on Capital Employed (ROCE)

-102.40%

Return on Assets (ROA)

-54.90%

Operating Profit Margin

-829.9%

Net Profit Margin

-6573.55%

Gross Profit Margin

-5,838.7%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Slowing versus 3-year growth rate

-88.1%

Operating Profit Growth (1 Year)

Net Profit Growth (1 Year)

Asset Quality

Promoter Holding

23.88%

Pledged shares (%) of Promoter's holding (%)

89.78%

Reserves

₹-134 Cr.

Equity

₹98.7 Cr.

Face Value

₹10

All Time Low / High

₹0.38 / 45.81

Hiran Orgochem stock performance

Key Ratios

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'06	Mar'07	Mar'08	Mar'09	Mar'10	Jun'11	Jun'12	Jun'13	Mar'14	Mar'15	TTM
ROCE % ⓘ	41.4%	7.4%	9.1%	-11.4%	15.4%	-50.2%	-5.6%	-65.6%	-12.5%	-102.4%	-
Growth Parameters ⓘ
Sales ⓘ	115	108	119	189	203	118	38.9	24	3.5	0.4	0
Sales YoY Gr.	-	-5.9%	9.9%	58.4%	7.6%	-41.7%	-67.1%	-38.4%	-85.3%	-88.1%	-
Adj EPS ⓘ	3.5	0.2	0.6	-2.3	0.6	-6.7	-1.3	-6.1	-1	-1	0.1
YoY Gr.	-	-94.6%	200%	-500%	NA	-1268.4%	NA	NA	NA	NA	-
BVPS (₹) ⓘ	12.2	16	16.6	13.6	14.9	3.4	3.3	-2.8	-4.7	-6.3	-3.5
Adj Net Profit ⓘ	13.5	1	3	-12	3	-65.7	-13	-59.7	-9.6	-10.2	1
Cash Flow from Ops. ⓘ	-17.6	-41	4.6	20.8	11.9	-45.3	3.8	-28.6	-1.2	-16.1	-
Debt/CF from Ops. ⓘ	-1.9	-1.2	12.4	2.5	4.5	-1.7	23.2	-3.1	-92.5	-4.1	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	-46.4%	-71%	-77.9%	-88.1%
Adj EPS ⓘ	-187.3%	-212.6%	NA	NA
BVPSⓘ	-193%	-184.2%	-224.4%	NA
Share Price	-	-	-	-

Key Financial Parameters ⓘ

	Mar'06	Mar'07	Mar'08	Mar'09	Mar'10	Jun'11	Jun'12	Jun'13	Mar'14	Mar'15	TTM
Return on Equity % ⓘ	43.2	1.5	3.5	-15.1	3.9	-136.1	-35	-2278.6	23.3	21	-1.8
Op. Profit Mgn % ⓘ	21.1	7.2	9.8	-3.7	6.3	-45.5	-31.4	-244	-243.2	-829.9	NAN
Net Profit Mgn % ⓘ	11.7	0.9	2.5	-6.4	1.5	-55.5	-33.4	-249	-272.7	-2416.2	INF
Debt to Equity ⓘ	0.7	0.6	0.7	0.7	0.7	2.3	2.8	-3.2	-2.5	-1.1	-
Working Cap Days ⓘ	175	354	424	266	262	346	884	906	5,426	24,780	0
Cash Conv. Cycle ⓘ	48	120	112	47	23	72	-23	-110	-782	-6,807	0

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'06	Mar'07	Mar'08	Mar'09	Mar'10	Jun'11	Jun'12	Jun'13	Mar'14	Mar'15
Sales	115.14	108.37	119.05	188.57	202.96	147.85	38.93	23.97	2.65	0.42
Operating Expenses ⓘ +	91.04	100.65	107.35	203.35	190.30	215.55	51.48	82.92	9.09	29
Manufacturing Costs	5.04	8.08	5.31	6.37	7.11	5.52	2.28	0.44	0.03	0.05
Material Costs	75.92	84.68	93.75	179.25	172.26	198.35	36.91	22.73	2.54	0.42
Employee Cost	2.91	3.18	3.49	4.15	4.03	3.87	1.50	0.76	0.12	0.13
Other Costs ⓘ	7.16	4.71	4.79	13.57	6.91	7.80	10.79	59	6.40	28.40
Operating Profit ⓘ	24.10	7.72	11.71	-14.78	12.66	-67.70	-12.55	-58.95	-6.44	-28.58
Operating Profit Margin (%)	20.9%	7.1%	9.8%	-7.8%	6.2%	-45.8%	-32.2%	-246.0%	-243.0%	-6,768.9%
Other Income ⓘ +	1.11	1.75	2.68	1.66	9.27	3.29	7.95	1.51	0.92	0.88
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	3.62	5.17	7.58	9.99	9.09	15.22	1.90	0.08	0.18	0.01
Depreciation ⓘ	1.26	1.62	1.83	2.12	2.33	3.20	2.60	2.49	1.51	0.05
Profit Before Tax ⓘ	20.33	2.68	4.98	-25.22	10.51	-82.84	-9.09	-60.01	-7.22	-27.76
Tax ⓘ	6.94	1.60	1.09	-7.85	3.06	0.54	0	0	0	0
Profit After Tax	13.38	1.08	3.88	-17.38	7.45	-83.38	-9.09	-60.01	-7.22	-27.76
PAT Margin (%)	11.6%	1.0%	3.3%	-9.2%	3.7%	-56.4%	-23.4%	-250.0%	-272.0%	-6,573.6%
Adjusted EPS (₹)	3.5	0.2	0.7	-3.3	1.4	-8.5	-0.9	-6.1	-0.7	-2.8
Dividend Payout Ratio (%)	8.70%	48.80%	13.50%	-1.20%	0%	0%	0%	0%	0%	0%

Valuation of Hiran Orgochem - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'06	Mar'07	Mar'08	Mar'09	Mar'10	Jun'11	Jun'12	Jun'13	Mar'14	Mar'15
Equity and Liabilities
Shareholders Fund +	47.07	84.19	87.46	71.50	78.95	41.72	32.62	-27.39	-34.60	-62.36
Share Capital ⓘ	7.72	10.50	10.50	10.50	52.50	98.66	98.66	98.66	98.66	98.66
Reserves ⓘ	39.34	73.69	76.96	61	26.44	-56.94	-66.03	-126.04	-133.26	-161.02
Debt +	32.75	47.89	56.66	51.62	53.70	96.08	88.97	88.71	85.70	65.46
Long Term Debt	32.75	47.89	56.66	51.62	53.70	0.62	0.54	0.50	0.68	0.69
Short Term Debt	0	0	0	0	0	95.46	88.43	88.21	85.03	64.77
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	27.84	31.47	49.19	61.35	76.11	48.82	25.23	21.88	22.35	20.25
Others Liabilities ⓘ	11.98	12.88	8.32	0.43	13.01	6.92	5.72	3.65	2.16	2.14
Total Liabilities ⓘ	119.63	176.42	201.62	184.90	221.77	193.53	152.55	86.86	75.61	25.49
Fixed Assets
Net Fixed Assets ⓘ +	27.56	31.68	35.95	36.53	37.04	38.78	35.58	33.08	31.57	0.20
Gross Block	32.42	37.98	44.08	46.75	49.54	54.11	53.32	53.20	53.20	0.36
Accumulated Depreciation	4.86	6.30	8.13	10.22	12.50	15.34	17.74	20.12	21.63	0.16
CWIP ⓘ	1.22	0.57	2.26	1.26	0.13	0.04	0.04	0.04	0	0
Investments ⓘ	2.52	0.78	0.89	2.90	4.80	4.69	4.69	4.59	4.59	0
Inventories	43.04	62.68	68.23	51.97	69.36	12.92	3.76	1.07	1.07	1.07
Trade Receivables	19.66	17.28	29.12	17.71	41.43	29.74	19.85	7.79	8.32	0.37
Cash Equivalents	2.99	4.59	4.46	7.27	8.91	25.11	27.97	0.10	0.14	0.18
Others Assets ⓘ	22.64	58.85	60.71	67.26	60.09	82.25	60.65	40.18	29.92	23.67
Total Assets ⓘ	119.63	176.42	201.62	184.90	221.77	193.53	152.55	86.86	75.61	25.49

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'06	Mar'07	Mar'08	Mar'09	Mar'10	Jun'11	Jun'12	Jun'13	Mar'14	Mar'15
Cash Flow From Operating Activity ⓘ +	-17.59	-41	4.58	20.76	11.90	-56.67	3.84	-28.64	-0.93	-16.08
PBT ⓘ	20.33	2.68	4.98	-25.22	10.51	-82.84	-9.09	-60.01	-7.22	-27.76
Adjustment ⓘ	4.18	4.69	6.22	12.99	13.46	14.49	-2.48	1.95	0.77	19.84
Changes in Working Capital ⓘ	-37.9	-45.28	-5.6	33.52	-11.86	11.78	15.61	28.2	5.52	-8.16
Tax Paid ⓘ	-4.20	-3.09	-1.01	-0.52	-0.21	-0.10	-0.20	1.23	0	0
Cash Flow From Investing Activity ⓘ +	-9	-3.24	-6.58	-2.64	-1.29	-0.49	2.28	1.44	0.96	16.13
Capex	-7.24	-5.03	-7.81	-2.24	-1.92	-5.11	0.29	0.01	0.05	10.65
Net Investments	-2.43	0.76	-0.11	-2.01	-1.90	0.11	0	0.07	0	0
Others ⓘ	0.67	1.03	1.33	1.61	2.53	4.51	1.99	1.36	0.91	5.48
Cash Flow From Financing Activity ⓘ +	27.23	45.84	1.87	-15.32	-8.96	73.97	-9.01	-0.35	-0	0
Net Proceeds from Shares ⓘ	19.50	36.10	0	0	0	46.15	0	-0.27	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	0	0	0	0
Interest Paid ⓘ	-3.40	-4.64	-6.80	-9.30	-8.63	-14.62	-1.90	-0.08	-0.18	-0.01
Dividend Paid ⓘ	-0.93	-1.16	-0.53	-0.53	-0.21	0	0	0	0	0
Others ⓘ	12.06	15.54	9.20	-5.50	-0.12	42.44	-7.11	0	0.18	0.01
Net Cash Flow ⓘ	0.63	1.60	-0.13	2.81	1.64	16.81	-2.89	-27.55	0.04	0.05

Financial Ratio

PARTICULARS	Mar'06	Mar'07	Mar'08	Mar'09	Mar'10	Jun'11	Jun'12	Jun'13	Mar'14	Mar'15
Ratios
ROE (%)	42.83	1.64	4.53	-21.88	9.95	-139.48	-24.71	N/A	N/A	N/A
ROCE (%)	41.35	7.42	9.1	-11.41	15.37	-50.2	-5.56	N/A	N/A	N/A
Asset Turnover Ratio	1.38	0.78	0.68	1.05	1.05	0.75	0.25	0.22	0.04	0.01
PAT to CFO Conversion(x)	-1.31	-37.96	1.18	N/A	1.6	N/A	N/A	N/A	N/A	N/A
Working Capital Days
Receivable Days	43.30	58.40	66.30	42.20	50.40	83.70	210.40	188.30	989.30	3,341.50
Inventory Days	94.60	167.20	186.90	108.40	103.50	96.70	70.80	32.90	131.70	824.80
Payable Days	105.30	127.80	157	112.50	145.60	114.90	366.10	378.30	3,177.70	0

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

66.33

88.83

88.84

90.61

90.21

89.78

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Hiran Orgochem Ltd FAQs

The current trading price of Hiran Orgochem on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Hiran Orgochem stood at ₹4.74 Cr

The latest P/E ratio of Hiran Orgochem as of 31-Dec-1969 is 5.56.

The latest P/B ratio of Hiran Orgochem as of 31-Dec-1969 is -0.14.

The 52-week high of Hiran Orgochem is ₹0.48 and the 52-week low is ₹0.44.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Hiran Orgochem is ₹0.00 ( Cr.) .

Data is not available for this company.

No data found

About Hiran Orgochem Ltd

Mumbai based Hiran Orgochem was Incorporated in 1983 is a leading integrated manufacturer of active pharmaceutical ingredients and formulations. Since its incorporation, Hiran has focused on Manufacturing the Quinolones group of API's with its principal products comprising Ciprofloxacin, Ofloxacin, Levofloxacin, Enrofloxacin and now provides formulations as well.

Hiran today is the largest Ciprofloxacin, Ofloxacin, Levofloxacin and Enrofloxacin manufacturer in India and strives to attain Global Leadership. The Company has achieved this position due to its strong commitment and ability to deliver unparalleled excellence in customer service. Hiran's Ability to provide services on a Quick-turn and cost-effective basis has resulted in successfully expanding its customer base and delivering solid operating returns.

The company is having presence in more than 56 Countries. Their Export percentage is about 40% - 45% of the total Sales Turnover. Currently we are working on approvals for US FDA, COS and TGA.

Product range of the company includes:

API

Ciprofloxacin HCL / Base
Ciprofloxacin Lactate
Ciprofloxacin HCL Compacted
Ciprofloxacin HCL Micronised
Ofloxacin HCL / Base
Levofloxacin Hemihydrate
Quinine Sulphate
Quinine BiSulphate
Quinine HCL
Quinine DiHCL

Veterinary Products

Enrofloxacin Base / HCL / Lactate
Difloxacin Base / HCL / Lactate
Sarafloxacin Base / HCL / Lactate

Products under development

Azithromycin
Clarithromycin
Omeprazole
Pantoprazole Sodium
Levocetirizine
Danofloxacin Mesylate
Fluconazole
Losartan Potassium
Atorvastatin
Simvastatin
Sildenafil Citrate
Moxifloxacin
Gemifloxacin
Lomefloxacin
Gatifloxacin
Pefloxacin

Hiran Orgochem Ltd (506170)

Hiran Orgochem Ltd (506170)

Hiran Orgochem stock performance

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Hiran Orgochem - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Hiran Orgochem Ltd FAQs

About Hiran Orgochem Ltd

Create stable, long-term investment portfolio with strong, consistent stocks.

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Hiran Orgochem Ltd (506170)

Hiran Orgochem Ltd (506170)

Hiran Orgochem stock performance

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Hiran Orgochem - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Hiran Orgochem Ltd FAQs

What is the share price of Hiran Orgochem?

What is the market cap of Hiran Orgochem?

What is the P/E ratio of Hiran Orgochem?

What is the P/B ratio of Hiran Orgochem?

What is the 52-week high and low of Hiran Orgochem?

What is the TTM revenue of Hiran Orgochem?

Is a good quality company?

Is undervalued or overvalued?

Is a good buy now?

About Hiran Orgochem Ltd

Create stable, long-term investment portfolio with strong, consistent stocks.

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.